TAMME SAFFA: Open Payments
NPI 1154392702 · CLAREMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 13 payments from 6 companies in 2025. Trend: 2023 $226 · 2024 $358 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $142 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $51 |
| Alkermes, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $21 |
Products named: SPRAVATO, Qelbree, VRAYLAR, ARISTADA, FANAPT, REXULTI.
Industry payments across OK — which companies pay providers there.
